HIV and Pregnancy – Safety of Anti-HIV Medications During Pregnancy
should also be avoided in the rst trimester of pregnancy. After the rst trimester, Sustiva or Atripla can be used safely.
Viramune increases the risk of very serious liver damage in women with CD4 counts greater than 250 cells/mm3. Vi- ramune should only be started in pregnant women with CD4 counts higher than 250 cells/mm3 if the benets very clearly outweigh the risks. Women who begin using Vira- mune during pregnancy are carefully monitored for early signs of liver damage. Women taking Viramune without problems before they become pregnant can safely continue to take the medication. Liver damage from Viramune use in pregnancy has not been seen in women already taking the medication without side eects.
Using NRTIs can sometimes lead to lactic acidosis, a con- dition caused by the buildup of a specic acid in the blood. Women should not take the combination of Zerit and
Videx during pregnancy because the combination has caused deaths from lactic acidosis and liver failure. Women taking NRTIs during pregnancy are watched carefully for signs of lactic acidosis.
Talk to your health care provider about the safety of anti-HIV medications during pregnancy. ere are many anti-HIV medications to choose from that will keep you and your baby healthy.
Contact an AIDSinfo health information specialist at 1–800– 448–0440 or visit http://aidsinfo.nih.gov. See your health care provider for medical advice.